AYTU BIOPHARMA, INC Increase (Decrease) in Inventories
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Inventories of -$2.39 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-09-22
- AYTU BIOPHARMA, INC increase (decrease) in inventories for the quarter ending 2026-06-30 was -$179.00K, a 134.56% decline year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in inventories for the quarter ending 2026-03-31 was -$543.00K, a 990.16% decline year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in inventories for the quarter ending 2025-12-31 was -$609.00K.
- AYTU BIOPHARMA, INC increase (decrease) in inventories for the quarter ending 2025-09-30 was -$1.06M.
- AYTU BIOPHARMA, INC increase (decrease) in inventories for fiscal 2026 was -$2.39M.
- AYTU BIOPHARMA, INC increase (decrease) in inventories for fiscal 2025 was -$382.00K, a 107.92% decline from fiscal 2024.
- AYTU BIOPHARMA, INC increase (decrease) in inventories for fiscal 2024 was $4.82M, a 33.58% increase from fiscal 2023.
- AYTU BIOPHARMA, INC increase (decrease) in inventories for fiscal 2023 was $3.61M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | -$722.00K derived: sum of 2 quarters · filed 2026-09-22 | -$1.33M derived: sum of 3 quarters · filed 2026-09-22 | -$2.39M 10-K · filed 2026-09-22 | ||||
| 2026-03-31 | -$543.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$1.15M derived: sum of 2 quarters · filed 2026-05-13 | -$2.21M 10-Q · filed 2026-05-13 | -$1.69M derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-12-31 | -$609.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$1.67M 10-Q · filed 2026-02-03 | -$1.15M derived: sum of 3 quarters · filed 2026-09-22 | -$1.09M derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-09-30 | -$1.06M 10-Q · filed 2025-11-13 | -$538.00K derived: sum of 2 quarters · filed 2026-09-22 | -$477.00K derived: sum of 3 quarters · filed 2026-09-22 | -$1.10M derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-06-30 | $518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $579.00K derived: sum of 2 quarters · filed 2026-09-22 | -$48.00K derived: sum of 3 quarters · filed 2026-09-22 | -$382.00K 10-K · filed 2026-09-22 | ||||
| 2025-03-31 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$566.00K derived: sum of 2 quarters · filed 2026-05-13 | -$900.00K 10-Q · filed 2026-05-13 | $1.11M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$627.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$961.00K 10-Q · filed 2026-02-03 | $1.05M derived: sum of 3 quarters · filed 2026-02-03 | $2.06M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-09-30 | -$334.00K 10-Q · filed 2025-11-13 | $1.68M derived: sum of 2 quarters · filed 2025-11-13 | -$334.00K 10-Q · filed 2024-11-13 | $3.46M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $3.02M derived: sum of 2 quarters · filed 2025-09-23 | $3.80M derived: sum of 3 quarters · filed 2025-09-23 | $4.82M 10-K · filed 2025-09-23 | $2.91M 10-K · filed 2024-09-26 | |||
| 2024-03-31 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $1.79M derived: sum of 2 quarters · filed 2025-05-14 | $2.81M 10-Q · filed 2025-05-14 | $1.67M 10-Q · filed 2024-05-15 | $3.43M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $782.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | $1.80M 10-Q · filed 2025-02-12 | $1.14M 10-Q · filed 2024-02-14 | $2.43M derived: sum of 3 quarters · filed 2025-02-12 | $3.23M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-09-30 | $1.02M 10-Q · filed 2023-11-14 | $1.65M derived: sum of 2 quarters · filed 2024-09-26 | $1.12M 10-Q · filed 2024-11-13 | $2.53M derived: sum of 4 quarters · filed 2024-09-26 | ||||
| 2023-06-30 | $622.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $1.43M derived: sum of 2 quarters · filed 2024-09-26 | $1.50M derived: sum of 3 quarters · filed 2024-09-26 | $3.61M 10-K · filed 2024-09-26 | ||||
| 2023-03-31 | $804.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $883.00K derived: sum of 2 quarters · filed 2024-05-15 | $2.99M 10-Q · filed 2024-05-15 | $1.78M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $2.18M 10-Q · filed 2024-02-14 | $975.00K derived: sum of 3 quarters · filed 2024-02-14 | $316.00K derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | $2.10M 10-Q · filed 2023-11-14 | $896.00K derived: sum of 2 quarters · filed 2023-11-14 | $237.00K derived: sum of 3 quarters · filed 2023-11-14 | $627.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | -$1.87M derived: sum of 2 quarters · filed 2023-10-12 | -$1.48M derived: sum of 3 quarters · filed 2023-10-12 | -$1.30M 10-K · filed 2023-10-12 | ||||
| 2022-03-31 | -$659.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -$269.00K derived: sum of 2 quarters · filed 2023-05-11 | -$91.00K 10-Q · filed 2023-05-11 | -$7.27M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $390.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-02-21 | $568.00K 10-Q · filed 2023-02-21 | -$6.61M derived: sum of 3 quarters · filed 2023-02-21 | -$5.83M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-09-30 | $178.00K 10-Q/A · filed 2023-02-21 | -$7.00M derived: sum of 2 quarters · filed 2023-02-21 | -$6.22M derived: sum of 3 quarters · filed 2023-02-21 | -$4.09M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | -$7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$6.40M derived: sum of 2 quarters · filed 2022-09-27 | -$4.27M derived: sum of 3 quarters · filed 2022-09-27 | -$2.79M 10-K · filed 2022-09-27 | ||||
| 2021-03-31 | $774.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $2.91M derived: sum of 2 quarters · filed 2022-05-16 | $4.39M 10-Q · filed 2022-05-16 | $4.39M 10-Q · filed 2021-05-17 | $12.26M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $3.62M 10-Q · filed 2022-02-14 | $3.62M 10-Q · filed 2021-02-11 | $11.49M derived: sum of 3 quarters · filed 2022-02-14 | $11.70M derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-09-30 | $1.48M 10-Q · filed 2021-11-15 | $1.48M 10-Q · filed 2020-11-12 | $9.35M derived: sum of 2 quarters · filed 2021-11-15 | $9.56M derived: sum of 3 quarters · filed 2021-11-15 | $9.76M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $7.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $8.08M derived: sum of 2 quarters · filed 2021-09-28 | $8.28M derived: sum of 3 quarters · filed 2021-09-28 | $8.22M 10-K · filed 2021-09-28 | $6.95M 10-K · filed 2020-10-06 | |||
| 2020-03-31 | $213.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $404.79K derived: sum of 2 quarters · filed 2021-05-17 | $345.45K 10-Q · filed 2021-05-17 | $255.44K derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $191.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | $132.20K 10-Q · filed 2021-02-11 | $42.19K derived: sum of 3 quarters · filed 2021-02-11 | -$72.59K derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-09-30 | -$59.34K 10-Q · filed 2020-11-12 | -$149.35K derived: sum of 2 quarters · filed 2020-11-12 | -$264.13K derived: sum of 3 quarters · filed 2020-11-12 | $70.63K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | -$90.01K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | -$204.79K derived: sum of 2 quarters · filed 2020-10-06 | $129.97K derived: sum of 3 quarters · filed 2020-10-06 | $101.10K 10-K · filed 2020-10-06 | ||||
| 2019-03-31 | -$114.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $219.98K derived: sum of 2 quarters · filed 2020-05-15 | $191.11K 10-Q · filed 2020-05-15 | $646.26K derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $334.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $305.89K 10-Q · filed 2020-02-14 | $761.04K derived: sum of 3 quarters · filed 2020-02-14 | $265.06K derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-09-30 | -$28.87K 10-Q · filed 2019-11-14 | $426.28K derived: sum of 2 quarters · filed 2019-11-14 | -$69.70K derived: sum of 3 quarters · filed 2019-11-14 | $138.84K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $455.15K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | -$40.83K derived: sum of 2 quarters · filed 2019-09-26 | $167.71K derived: sum of 3 quarters · filed 2019-09-26 | $26.75K 10-K · filed 2019-09-26 | ||||
| 2018-03-31 | -$495.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | -$287.44K derived: sum of 2 quarters · filed 2019-05-14 | -$428.40K 10-Q · filed 2019-05-14 | -$332.84K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $208.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | $67.58K 10-Q · filed 2019-05-14 | $163.14K derived: sum of 3 quarters · filed 2019-05-14 | -$42.10K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-09-30 | -$140.96K 10-Q · filed 2018-11-07 | -$45.40K derived: sum of 2 quarters · filed 2018-11-07 | -$250.65K derived: sum of 3 quarters · filed 2018-11-07 | -$397.04K derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | $95.56K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | -$109.69K derived: sum of 2 quarters · filed 2018-09-06 | -$256.08K derived: sum of 3 quarters · filed 2018-09-06 | -$195.43K 10-K · filed 2018-09-06 | ||||
| 2017-03-31 | -$205.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$351.63K derived: sum of 2 quarters · filed 2018-05-14 | -$290.98K 10-Q · filed 2018-05-14 | -$387.63K derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | -$146.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | -$85.74K 10-Q · filed 2018-02-08 | -$182.39K derived: sum of 3 quarters · filed 2018-02-08 | -$214.15K derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-09-30 | $60.65K 10-Q · filed 2017-11-09 | -$35.99K derived: sum of 2 quarters · filed 2017-11-09 | -$67.76K derived: sum of 3 quarters · filed 2017-11-09 | $91.28K derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | -$96.64K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | -$128.41K derived: sum of 2 quarters · filed 2017-08-31 | $30.63K derived: sum of 3 quarters · filed 2017-08-31 | $485.26K 10-K · filed 2017-08-31 | ||||
| 2016-03-31 | -$31.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $127.27K derived: sum of 2 quarters · filed 2017-05-11 | $581.91K 10-Q · filed 2017-05-11 | $610.12K derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $159.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $613.67K 10-Q · filed 2017-02-09 | $641.88K derived: sum of 3 quarters · filed 2017-02-09 | $642.66K derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-09-30 | $454.64K 10-Q · filed 2016-11-07 | $482.85K derived: sum of 2 quarters · filed 2016-11-07 | $483.63K derived: sum of 3 quarters · filed 2016-11-07 | |||||
| 2015-06-30 | $28.21K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $28.99K derived: sum of 2 quarters · filed 2016-09-01 | $39.44K 10-K · filed 2016-09-01 | |||||
| 2015-03-31 | $780.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | $11.23K 10-Q · filed 2016-05-11 | ||||||
| 2014-12-31 | $10.45K 10-Q · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |